Wang Z, Wu Q. Advancements in non-invasive diagnosis of gastric cancer. World J Gastroenterol 2025; 31(6): 101886 [DOI: 10.3748/wjg.v31.i6.101886]
Corresponding Author of This Article
Zhen Wang, MD, PhD, Doctor, Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jeifang Avenue, Jianghan District, Wuhan 430022, Hubei Province, China. wangzhen1993@hust.edu.cn
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Feb 14, 2025; 31(6): 101886 Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.101886
Advancements in non-invasive diagnosis of gastric cancer
Zhen Wang, Qi Wu
Zhen Wang, Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China
Qi Wu, Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China
Co-corresponding authors: Zhen Wang and Qi Wu.
Author contributions: Wang Z and Wu Q contributed to conceptualization, writing, reviewing, and editing; all of the authors read and approved the final version of the manuscript to be published.
Supported by National Natural Science Foundation of China, No. 82300451; and Research Foundation of Wuhan Union Hospital, No. 2022xhyn050.
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhen Wang, MD, PhD, Doctor, Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jeifang Avenue, Jianghan District, Wuhan 430022, Hubei Province, China. wangzhen1993@hust.edu.cn
Received: September 29, 2024 Revised: December 8, 2024 Accepted: December 20, 2024 Published online: February 14, 2025 Processing time: 102 Days and 16.3 Hours
Abstract
Gastric cancer (GC), a multifaceted and highly aggressive malignancy, represents challenging healthcare burdens globally, with a high incidence and mortality rate. Although endoscopy, combined with histological examination, is the gold standard for GC diagnosis, its high cost, invasiveness, and specialized requirements hinder widespread use for screening. With the emergence of innovative technologies such as advanced imaging, liquid biopsy, and breath tests, the landscape of GC diagnosis is poised for radical transformation, becoming more accessible, less invasive, and more efficient. As the non-invasive diagnostic techniques continue to advance and undergo rigorous clinical validation, they hold the promise of significantly impacting patient outcomes, ultimately leading to better treatment results and improved quality of life for patients with GC.
Core Tip: Non-invasive diagnostic methods for gastric cancer (GC) involve various techniques that minimize patient discomfort and potential complications. These approaches aim to detect early signs of the disease or identify individuals at risk for GC.
